Nectar Lifesciences Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Nectar Lifesciences Company Profile :

Nectar Lifesciences Limited is an Indian pharmaceutical company engaged in the business of providing drugs and pharmaceuticals.

The Company’s business activities include contract research and manufacturing services, active pharmaceutical ingredient (API) and intermediates, formulations, generics and over the counter (OTC), diagnostics, empty hard gelatin capsules and menthol.

Company’s products include Cefixime Trihydrate, Cefuroxime Axetil (Amorphous), Cefpodoxime Proxetil, Cefuroxime Sodium (Sterile), Ceftazidime (Buffered), Cephalothin (Buffered), Cefazolin Sodium (Sterile), Cefprozil, Cefoperzone Sodium (Sterile), Cefpirome Sulphate (Buffered) and Cefoxitin Sodium (Sterile).


Nectar Lifesciences ResultsBSE Code : 532649
NSE Symbol :  NECLIFE
ISIN No. : INE023H01027
Industry :  Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Nectar Lifesciences or you are an stock market analyst then i am sure you might for Quarterly Results of Nectar Lifesciences.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Nectar Lifesciences. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Nectar Lifesciences.

Nectar Lifesciences Q1 Results 2016-17 :

Nectar Lifesciences will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Nectar Lifesciences will announce its Q2 FY 2016-17 Results in the month of October 2016.

Nectar Lifesciences will announce its Q3 FY 2016-17 Results in the month of January 2017.

Nectar Lifesciences will announce its Q4 FY 2016-17 Results in the month of April 2017.

Nectar Lifesciences will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Nectar Lifesciences Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 1676.44 1675.81
Other Income  5.63  5.63
Total Income  1682.07  1681.44
Expenditure  -1401.70  -1486.44
Interest  -122.50  -122.50
Depreciation  -85.29  -85.29
PBT  72.58  72.49
Tax  -13.30  -13.29
Net Profit  59.28  59.19
Equity  22.43  22.43
EPS  2.64  2.64

Note : If you like this information about Nectar Lifesciences Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.